Author: Tomasz Jan Gomoła
Affiliation: DeepSensi Medical OS — Cognitive Infrastructure Division
Date: June 2026
Classification: Public White Paper — Companion to DSS, FTA, and The Flawed Yardstick
Status: Published for Open Peer Review
The evaluation of physician quality has, for centuries, relied on informal, socially mediated proxies: institutional affiliation, seniority, peer esteem, and publication count. Each of these proxies correlates imperfectly with clinical performance and carries systemic biases that disadvantage physicians outside elite academic networks, particularly those in underserved regions. The advent of verifiable clinical AI—systems whose diagnostic reasoning is recorded, auditable, and mathematically bounded in its error rate—creates, for the first time, the technical conditions for an objective, continuous, and bias-resistant measurement of physician quality. This paper presents the Global Clinical Performance Score (GCPS), a formal, five-axis framework for quantifying physician clinical cognition based exclusively on verified interactions within a multi-agent verification architecture. The GCPS is not a rating assigned by committee. It is a metric accumulated through cryptographically auditable events, designed to reward diagnostic accuracy, intellectual contribution, and—critically—the safe acknowledgment of uncertainty. We describe the mathematical architecture of the GCPS, its integration with the outcome-gated physician royalty economy, its anti-gaming defenses, and its role in creating the first global meritocracy of clinical talent.
Every profession has a reputation economy. In medicine, that economy has historically operated on signals that are legible but often misleading. A physician trained at a prestigious university hospital, publishing in high-impact journals, and holding a senior academic title is assumed—by patients, by peers, by insurers—to be clinically excellent. The assumption may be correct. It may also be entirely unfounded. No mechanism currently exists to verify it.
The proxies upon which medical reputation is built—institutional affiliation, publication count, seniority, the esteem of one's colleagues—share a common flaw: they are socially mediated. Social mediation introduces biases that are well documented and stubbornly resistant to correction. Physicians at elite institutions are assumed competent by association. Physicians who publish in English-language journals are more visible than those who publish in regional languages. Physicians who are well-connected receive more referrals, which increases their case volume, which increases their perceived expertise—a feedback loop that amplifies initial privilege rather than clinical merit.
The consequence is a global misallocation of trust. Brilliant diagnosticians practicing in community hospitals, rural clinics, and underserved regions are systematically undervalued. Their insights—hard-won through years of frontline clinical experience—remain invisible to the broader profession. Meanwhile, physicians whose clinical skills have atrophied behind administrative desks retain reputations built decades earlier. The system is not meritocratic. It never has been.
Artificial intelligence in medicine has, until recently, been evaluated exclusively on its own performance. The question asked of every model is: "How accurate is it?" The question has never been: "Can it measure the accuracy of the humans who use it?"
The emergence of verifiable clinical AI—systems whose diagnostic reasoning is recorded in an immutable audit trail and whose error rate is mathematically bounded—changes this. For the first time, a physician's clinical decisions can be compared against an objective, auditable standard. Not against the opinion of a senior colleague. Not against the reputation of their institution. Against the verified, cryptographically sealed record of whether their intervention moved the patient's clinical trajectory toward or away from the correct outcome.
This is the technical condition for a genuine meritocracy in medicine. It requires an architecture that records every decision, verifies every claim, and attributes every outcome. The Global Clinical Performance Score is built on exactly such an architecture.
The GCPS is not a single number. It is a composite of five independently measured axes, each representing a distinct dimension of clinical competence. The axes are weighted according to their clinical priority. The weights are fixed and public. The scoring algorithms for each axis are proprietary, but their operational logic is fully auditable.
Axis A1: Clinical Accuracy (Weight 35%). This axis measures the physician's diagnostic precision: whether their interventions moved the patient's clinical trajectory toward the correct outcome. It compares the physician's decisions against the final, verified diagnosis and the patient's Digital Twin health trajectory. A physician who consistently reduces the time to correct diagnosis accumulates a high score. A physician whose interventions repeatedly delay correct diagnosis—regardless of their reputation or seniority—sees their score decline.
Axis A2: Adversarial Error Detection (Weight 20%). This axis measures the physician's ability to identify and correct errors made by others—whether other physicians, AI specialists, or the broader diagnostic system. It rewards the cognitive skill of critical review: spotting a missed diagnosis, challenging an unsupported assumption, or identifying a flaw in another specialist's reasoning. A successful challenge that is subsequently validated by clinical outcome data increases this score. Repeated, unsubstantiated challenges that waste collective resources decrease it.
Axis A3: Knowledge Quality and Uniqueness (Weight 25%). This axis measures the intellectual value that a physician contributes to the platform's collective knowledge base. When a physician submits a clinical protocol, a diagnostic heuristic, or a novel hypothesis that is validated by peer review and subsequently applied in other cases across the network, their score on this axis increases. The magnitude of the increase is proportional to the impact of the contribution: how widely it is adopted and how significantly it improves outcomes. Falsified contributions—those that fail under empirical scrutiny—decrease the score.
Axis A4: Integrity Coefficient (Weight 15%). This axis measures the physician's commitment to safety and intellectual honesty. It rewards behaviors that are foundational to safe clinical practice but are rarely incentivized: correctly using the LIMBO protocol to acknowledge uncertainty, self-correcting a previous error, and refusing to offer a confident diagnosis when the data are insufficient. It penalizes presumptive diagnosis—generating a complete, confident answer in a case flagged as having insufficient data. This axis serves as a counterweight to the natural incentive to appear knowledgeable at the expense of being safe.
Axis A5: Cognitive Bias Resilience (Weight 5%). This axis is a passive, long-term measurement of the physician's resistance to systematic cognitive errors. It is derived from continuous analysis by the BiasDetector, which monitors decision patterns for evidence of anchoring, confirmation bias, premature closure, and other well-documented cognitive pitfalls. A low incidence of detected biases over a rolling window results in a high score. This axis has the slowest dynamics and is intended as a stability metric—a measure of the physician's underlying cognitive hygiene.
The GCPS is not a lifetime achievement award. It is a measure of current clinical competence. All axis scores are subject to temporal decay: recent performance carries greater weight than historical performance. The effective score for each axis is calculated as a time-weighted average with a half-life of 180 days. This ensures that a physician who was excellent a decade ago but has not maintained their skills will see their score decline, while a physician who has improved rapidly will see their score rise without being anchored by a long history of mediocrity.
The GCPS is not available immediately upon registration. A physician must complete an incubation period—active participation in a minimum of 50 verified clinical cases as a Sentinel—before their score is activated and made publicly visible. During this period, the score is calculated internally but is not displayed. This serves three purposes. First, it prevents a physician from creating a new account to escape a poor reputation. Second, it ensures that the initial public score is based on a statistically meaningful sample of clinical behavior. Third, it gives new physicians time to learn the platform's safety protocols and cognitive norms before their performance is measured against the global network.
The continuous GCPS Core score is mapped to four discrete trust levels: Bronze (GCPS below 50), Silver (50–69), Gold (70–84), and Platinum (85 and above). These levels govern a physician's influence within the Hyper Consilium, their eligibility for premium diagnostic challenges, and their economic returns from the platform.
Physicians in the Platinum tier receive the highest weight in swarm voting, priority in automated specialist selection for Real-Time Multi-Sentinel Consilium events, and a royalty multiplier applied to their earnings from the Physician Knowledge Royalties pool (CWPD v2). Physicians in the Bronze tier have minimal voting weight, no access to Hyper Consilium Live invitations, and no royalty multiplier. The system is designed so that excellence is not merely recognized—it is tangibly rewarded, and poor performance has tangible consequences.
Any reputation system that relies on peer evaluation is vulnerable to collusion. The GCPS incorporates real-time graph analysis of validation patterns among physicians. Clusters of physicians with a statistically anomalous density of mutual approvals are automatically flagged. Their validations of each other's skills and protocols are excluded from the GCPS calculation for the affected axes.
The Integrity Coefficient (Axis A4) is algorithmically constrained against rapid artificial inflation. A physician cannot achieve a high score on this axis by repeatedly performing low-risk LIMBO activations. The scoring algorithm places a premium on appropriate LIMBO usage in complex, high-uncertainty cases, which carry greater weight than routine safety checks.
A physician who commits a catastrophic clinical error—a recommendation with a high probability of causing immediate, severe patient harm—triggers an automatic Sentinel Ban. Their voting weight is frozen at the minimum, their trust level is downgraded to Bronze, and they are removed from all automated Hyper Consilium Live invitations. They retain read-only access to patient data, preserving their ethical duty of care, but can no longer influence diagnostic consensus. Restoration requires passing an enhanced cognitive bias examination. The ban record remains permanently on the internal profile but is not publicly displayed, balancing accountability with the possibility of rehabilitation.
The highest GCPS scores are not hidden. They are published in an anonymized, publicly accessible registry: the Global Meritocracy Ledger. Each entry displays a cryptographic alias, a specialty, a trust level, and the GCPS Core score. No personally identifiable information is revealed. A patient, a hospital, or an insurer can verify that "Cardiologist #4521" has a GCPS of 94 and is in the Platinum tier, without knowing the physician's name or institution. This creates, for the first time, a global market for clinical talent in which the currency is verified competence rather than social signaling.
The GCPS does not merely add a feature to a clinical AI platform. It changes the incentive structure of medical reputation. Under the GCPS regime, a physician in a rural clinic whose diagnostic accuracy is exceptional is visible to the entire network. A physician at a prestigious academic center whose clinical skills are mediocre is exposed. Neither institution nor nationality nor connections can mask the signal.
This has consequences for patients, who can—for the first time—identify the physicians with the highest verified clinical performance. It has consequences for hospitals, which can recruit based on demonstrated competence rather than credentials. It has consequences for insurers, who can price malpractice coverage based on objective, auditable risk. And it has consequences for the profession itself, which can begin the long process of replacing a reputation system built on affiliation with one built on evidence.
The GCPS is not a rating. It is not a review. It is an architectural commitment to the principle that the best physician should be recognized as such—not because of where they trained or who they know, but because of the measurable quality of their clinical mind.
The GCPS is a companion to the Gomola Framework, the open, royalty-free certification standard for clinical AI safety described in a separate publication. Where the Gomola Framework defines the pillars of a safe AI system, the GCPS defines the pillars of a measurable physician. Together, they form a complete architecture of trust: the system is verified, and the humans who use it are verified. Neither trust in the machine nor trust in the physician rests on opinion. Both rest on evidence.
For as long as medicine has existed, the reputation of a physician has been a matter of belief. We believe in the competence of our doctors because they trained at institutions we respect, because they speak with authority, because others in the profession vouch for them. That era is ending. The technical conditions now exist to replace belief with evidence, and reputation with measurement. The Global Clinical Performance Score is a proposal for how that transition should be made: not by replacing physician judgment with algorithmic judgment, but by surrounding physician judgment with an architecture of verification that makes the best among them visible, recognized, and rewarded.
Disclosures: Tomasz Jan Gomoła is the founder and chief architect of DeepSensi PBC, which operates the first production implementation of the GCPS. The GCPS methodology described in this paper is offered as an open, royalty-free framework for academic and clinical adoption. The reference implementation within DeepSensi is proprietary and commercially licensed.
Corresponding Author: Tomasz Jan Gomoła, Founder and Chief Architect, DeepSensi PBC, USA. tomasz@deepsensi.com. https://deepsensi.com
Recommended Citation: Gomoła, T.J. (2026). "The Global Clinical Performance Score: A Formal Framework for Objective, Bias-Resistant Physician Reputation in the Age of Verified Clinical Intelligence." White Paper WP-004. DeepSensi Medical OS.